Respira

Liquidia Technologies

This biopharmaceutical company develops inhaled therapies for patients with pulmonary arterial hypertension and other cardiopulmonary diseases using a proprietary particle engineering platform.

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.

Savara

This biopharmaceutical company develops inhaled therapies for patients with rare respiratory diseases, such as autoimmune pulmonary alveolar proteinosis.

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.